Marsh & McLennan Companies, Inc. MRSH
Composite 58/100; the shares have moved about 28% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 45/100 — a slight mark against it.
Quality ranks 70/100 — a moderate point in its favour. Income ranks 61/100 — a slight point in its favour. Growth ranks 59/100 — a slight point in its favour.
Valuation ranks 45/100 — a slight mark against it.
What the company does Marsh & McLennan provides risk, strategy, and people advisory services through two segments: Risk and Insurance Services (broking, consulting, analytics) and Consulting (health, wealth, career solutions). It serves corporations, insurers, and public entities globally with a history dating to 1871.
Key financials ROE 25.9%, ROA 7.2%, gross/operating/net margins 44.0%/26.3%/14.2%. Revenue growth 10.3%, EPS growth 5.6%. Debt/Equity 1.45, net debt/EBITDA 2.67, current ratio 1.14. Dividend yield 2.1%, payout 36.1%.
Stock health Sideravia scores: Overall 58.5 (average quality, fairly valued), Quality 70.0, Growth 61.4, Strength 58.7, Valuation 44.1, Momentum 54.7, Income 60.3. Piotroski F-Score 7/9. RSI(14) 56.10.
Price vs fair value Marsh & McLennan trades at a discount of 8.60% versus the analyst mean target of 205.52. - Recent headlines highlight insurance risks for large tech projects (Meta’s Texas AI data center) and mixed brokerage sentiment (Barchart). - Clean Harbors’ gains underscore sector volatility, potentially affecting risk appetite (Zacks). - Forward P/E 18.35 and PEG 0.67 suggest valuation support relative to growth.
Looking forward Forward P/E 18.35 and PEG 0.67 indicate potential valuation support. Revenue growth of 10.3% and strong profitability metrics (ROE 25.9%) reflect operational strength. Momentum remains mixed, with 12-month performance at -7.01%.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.